Stock CHINA VANGUARD GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News China Vanguard Group Limited Deutsche Boerse AG

Equities

KYG2159V1095

End-of-day quote Deutsche Boerse AG
Other stock markets
- EUR - Intraday chart for China Vanguard Group Limited
02-29 Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 Sinopharm Tech Holdings Limited Announces Management Changes CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Sinopharm Tech Holdings Limited Announces Management Changes
CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the First Quarter Ended September 30, 2023
CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Sinopharm Tech Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2023
CI
Sinopharm Tech Holdings Limited Announces Change of Head Office and Principal Place of Business in Hong Kong
CI
Sinopharm Tech Holdings Limited Appoints HEUNG Pik Lun as an Independent Non-Executive Director and A Member of the Audit Committee and the Nomination Committee
CI
Reverse Split: 1 of 25
FA
Sinopharm Tech Holdings Limited Announces Appointment of Mr. Hsu Dong an as an Independent Non-Executive Director, Chairperson of the Nomination Committee and Member of the Audit Committee, the Remuneration Committee and the Nomination Committee
CI
Sinopharm Tech Holdings Limited Announces Liu Ta-Pei Resigns as an Independent Non-Executive Director, Member of the Audit Committee the Remuneration Committee and the Nomination Committee
CI
Sinopharm Tech Holdings Limited Announces the Resignation of LAM Kit Sun as Independent Non-Executive Director, Member of the Audit Committee and the Remuneration Committee and the Chairperson and Member of the Nomination Committee
CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
CI
Sinopharm Tech Holdings Limited Provides Group Earnings Guidance for the Nine Months Ended 31 March 2023
CI
Sinopharm Tech : CHARACTERISTICS OF GEM (“GEM”) OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”)
PU
Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
CI
Sinopharm Tech Holdings Provides Earnings Guidance for the Six Months Ended December 31, 2022
CI
Sinopharm Tech Holdings Limited and Guangdong Tongguanyi Network Technology Co., Ltd. enters into A Joint Venture Agreement to Establish A Joint Venture
CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the First Quarter Ended September 30, 2022
CI
Sinopharm Tech Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Three Months Ended 30 September 2022
CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8156 Stock
  4. Stock
  5. News China Vanguard Group Limited